-
Je něco špatně v tomto záznamu ?
Expression of lipogenic markers is decreased in subcutaneous adipose tissue and adipocytes of older women and is negatively linked to GDF15 expression
V. Šrámková, M. Koc, E. Krauzová, J. Kračmerová, M. Šiklová, M. Elkalaf, D. Langin, V. Štich, L. Rossmeislová,
Jazyk angličtina Země Španělsko
Typ dokumentu srovnávací studie, časopisecké články
Grantová podpora
NV16-29182A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
NLK
Medline Complete (EBSCOhost)
od 2000-03-01 do Před 1 rokem
- MeSH
- biologické markery metabolismus MeSH
- buněčná diferenciace MeSH
- dospělí MeSH
- lidé MeSH
- lipogeneze * MeSH
- mitochondrie metabolismus MeSH
- podkožní tuk metabolismus MeSH
- růstový diferenciační faktor 15 metabolismus MeSH
- senioři MeSH
- stárnutí buněk MeSH
- stárnutí metabolismus MeSH
- stres endoplazmatického retikula MeSH
- tukové buňky metabolismus MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- srovnávací studie MeSH
In aging, the capacity of subcutaneous adipose tissue (SAT) to store lipids decreases and this results in metabolically unfavorable fat redistribution. Triggers of this age-related SAT dysfunction may include cellular senescence or endoplasmic reticulum (ER) stress. Therefore, we compared lipogenic capacity of SAT between young and older women and investigated its relation to senescence and ER stress markers. Samples of SAT and corresponding SAT-derived primary preadipocytes were obtained from two groups of women differing in age (36 vs. 72 years, n = 15 each) but matched for fat mass. mRNA levels of selected genes (lipogenesis: ACACA, FASN, SCD1, DGAT2, ELOVL6; senescence: p16, p21, NOX4, GDF15; ER stress-ATF4, XBP1s, PERK, HSPA5, GADD34, HYOU1, CHOP, EDEM1, DNAJC3) were assessed by qPCR, protein levels of GDF15 by ELISA, and mitochondrial function by the Seahorse Analyzer. Compared to the young, SAT and in vitro differentiated adipocytes from older women exhibited reduced mRNA expression of lipogenic enzymes. Out of analyzed senescence and ER stress markers, the only gene, whose expression correlated negatively with the expression of lipogenic enzymes in both SAT and adipocytes, was GDF15, a marker of not only senescence but also mitochondrial dysfunction. In line with this, inhibition of mitochondrial ATP synthase in adipocytes strongly upregulated GDF15 while reduced expression of lipogenic enzymes. Moreover, adipocytes from older women had a tendency for diminished mitochondrial capacity. Thus, a reduced lipogenic capacity of adipocytes in aged SAT appears to be linked to mitochondrial dysfunction rather than to ER stress or accumulation of senescent cells.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20006504
- 003
- CZ-PrNML
- 005
- 20200527094154.0
- 007
- ta
- 008
- 200511s2019 sp f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s13105-019-00676-6 $2 doi
- 035 __
- $a (PubMed)30912009
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sp
- 100 1_
- $a Šrámková, Veronika $u Department of Pathophysiology, Third Faculty of Medicine, Charles University, Prague, Czech Republic. Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague, Czech Republic.
- 245 10
- $a Expression of lipogenic markers is decreased in subcutaneous adipose tissue and adipocytes of older women and is negatively linked to GDF15 expression / $c V. Šrámková, M. Koc, E. Krauzová, J. Kračmerová, M. Šiklová, M. Elkalaf, D. Langin, V. Štich, L. Rossmeislová,
- 520 9_
- $a In aging, the capacity of subcutaneous adipose tissue (SAT) to store lipids decreases and this results in metabolically unfavorable fat redistribution. Triggers of this age-related SAT dysfunction may include cellular senescence or endoplasmic reticulum (ER) stress. Therefore, we compared lipogenic capacity of SAT between young and older women and investigated its relation to senescence and ER stress markers. Samples of SAT and corresponding SAT-derived primary preadipocytes were obtained from two groups of women differing in age (36 vs. 72 years, n = 15 each) but matched for fat mass. mRNA levels of selected genes (lipogenesis: ACACA, FASN, SCD1, DGAT2, ELOVL6; senescence: p16, p21, NOX4, GDF15; ER stress-ATF4, XBP1s, PERK, HSPA5, GADD34, HYOU1, CHOP, EDEM1, DNAJC3) were assessed by qPCR, protein levels of GDF15 by ELISA, and mitochondrial function by the Seahorse Analyzer. Compared to the young, SAT and in vitro differentiated adipocytes from older women exhibited reduced mRNA expression of lipogenic enzymes. Out of analyzed senescence and ER stress markers, the only gene, whose expression correlated negatively with the expression of lipogenic enzymes in both SAT and adipocytes, was GDF15, a marker of not only senescence but also mitochondrial dysfunction. In line with this, inhibition of mitochondrial ATP synthase in adipocytes strongly upregulated GDF15 while reduced expression of lipogenic enzymes. Moreover, adipocytes from older women had a tendency for diminished mitochondrial capacity. Thus, a reduced lipogenic capacity of adipocytes in aged SAT appears to be linked to mitochondrial dysfunction rather than to ER stress or accumulation of senescent cells.
- 650 _2
- $a tukové buňky $x metabolismus $7 D017667
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a stárnutí $x metabolismus $7 D000375
- 650 _2
- $a biologické markery $x metabolismus $7 D015415
- 650 _2
- $a buněčná diferenciace $7 D002454
- 650 _2
- $a stárnutí buněk $7 D016922
- 650 _2
- $a stres endoplazmatického retikula $7 D059865
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a růstový diferenciační faktor 15 $x metabolismus $7 D055436
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a lipogeneze $7 D050155
- 650 _2
- $a mitochondrie $x metabolismus $7 D008928
- 650 _2
- $a podkožní tuk $x metabolismus $7 D050151
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Koc, Michal $u Department of Pathophysiology, Third Faculty of Medicine, Charles University, Prague, Czech Republic. Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague, Czech Republic.
- 700 1_
- $a Krauzová, Eva $u Department of Pathophysiology, Third Faculty of Medicine, Charles University, Prague, Czech Republic. Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague, Czech Republic. Second Department of Internal Medicine, University Hospital Kralovske Vinohrady, Prague, Czech Republic.
- 700 1_
- $a Kračmerová, Jana $u Department of Pathophysiology, Third Faculty of Medicine, Charles University, Prague, Czech Republic. Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague, Czech Republic.
- 700 1_
- $a Šiklová, Michaela $u Department of Pathophysiology, Third Faculty of Medicine, Charles University, Prague, Czech Republic. Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague, Czech Republic.
- 700 1_
- $a Elkalaf, Moustafa $u Department of Biochemistry, Cell and Molecular Biology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Langin, Dominique $u Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague, Czech Republic. INSERM, UMR1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France. Paul Sabatier University, Toulouse, France. Department of Clinical Biochemistry, Toulouse University Hospitals, Toulouse, France.
- 700 1_
- $a Štich, Vladimír $u Department of Pathophysiology, Third Faculty of Medicine, Charles University, Prague, Czech Republic. Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague, Czech Republic. Second Department of Internal Medicine, University Hospital Kralovske Vinohrady, Prague, Czech Republic.
- 700 1_
- $a Rossmeislová, Lenka $u Department of Pathophysiology, Third Faculty of Medicine, Charles University, Prague, Czech Republic. lenka.rossmeislova@lf3.cuni.cz. Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague, Czech Republic. lenka.rossmeislova@lf3.cuni.cz.
- 773 0_
- $w MED00181630 $t Journal of physiology and biochemistry $x 1877-8755 $g Roč. 75, č. 3 (2019), s. 253-262
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30912009 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20200527094151 $b ABA008
- 999 __
- $a ok $b bmc $g 1525362 $s 1096560
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 75 $c 3 $d 253-262 $e 20190325 $i 1877-8755 $m Journal of physiology and biochemistry $n J Physiol Biochem $x MED00181630
- GRA __
- $a NV16-29182A $p MZ0
- LZP __
- $a Pubmed-20200511